Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fahrner

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Proteomics|December 24, 2023
Integration of proteomics in the molecular tumor boardJohanna Thiery, Matthias Fahrner
Pathologie (Heidelberg, Germany)|November 24, 2023
Using proteomics for stratification and risk prediction in patients with solid tumorsTilman Werner, Matthias Fahrner, Oliver Schilling
Pathologie (Heidelberg, Germany)|November 7, 2024
Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnosticsTilman Werner, Matthias Fahrner, Oliver Schilling
Proteomes|June 2, 2021
A Systematic Evaluation of Semispecific Peptide Search Parameter Enables Identification of Previously Undescribed N-Terminal Peptides and Conserved Proteolytic Processing in Cancer Cell LinesMatthias Fahrner, Lucas Kook, Klemens Fröhlich, et al.
Neoplasia (New York, N.Y.)|November 12, 2021
Proteome biology of primary colorectal carcinoma and corresponding liver metastasesMatthias Fahrner, Peter Bronsert, Stefan Fichtner-Feigl, et al.
Gigascience|February 15, 2022
Democratizing data-independent acquisition proteomics analysis on public cloud infrastructures via the Galaxy frameworkMatthias Fahrner, Melanie Christine Föll, Björn Andreas Grüning, et al.
Cancer Cell International|February 26, 2020
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell deathHannah Maria Baumert, Eric Metzger, Matthias Fahrner, et al.
Molecular & Cellular Proteomics : MCP|June 16, 2024
Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry-Based ProteomicsKlemens Fröhlich, Matthias Fahrner, Eva Brombacher, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2021
Discovery of a small protein factor involved in the coordinated degradation of phycobilisomes in cyanobacteriaVanessa Krauspe, Matthias Fahrner, Philipp Spät, et al.
Clinical Proteomics|March 13, 2018
Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinizationMelanie Christine Föll, Matthias Fahrner, Victor Oginga Oria, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Proteomics|December 24, 2023
Integration of proteomics in the molecular tumor boardJohanna Thiery, Matthias Fahrner
Pathologie (Heidelberg, Germany)|November 24, 2023
Using proteomics for stratification and risk prediction in patients with solid tumorsTilman Werner, Matthias Fahrner, Oliver Schilling
Pathologie (Heidelberg, Germany)|November 7, 2024
Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnosticsTilman Werner, Matthias Fahrner, Oliver Schilling
Proteomes|June 2, 2021
A Systematic Evaluation of Semispecific Peptide Search Parameter Enables Identification of Previously Undescribed N-Terminal Peptides and Conserved Proteolytic Processing in Cancer Cell LinesMatthias Fahrner, Lucas Kook, Klemens Fröhlich, et al.
Neoplasia (New York, N.Y.)|November 12, 2021
Proteome biology of primary colorectal carcinoma and corresponding liver metastasesMatthias Fahrner, Peter Bronsert, Stefan Fichtner-Feigl, et al.
Gigascience|February 15, 2022
Democratizing data-independent acquisition proteomics analysis on public cloud infrastructures via the Galaxy frameworkMatthias Fahrner, Melanie Christine Föll, Björn Andreas Grüning, et al.
Cancer Cell International|February 26, 2020
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell deathHannah Maria Baumert, Eric Metzger, Matthias Fahrner, et al.
Molecular & Cellular Proteomics : MCP|June 16, 2024
Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry-Based ProteomicsKlemens Fröhlich, Matthias Fahrner, Eva Brombacher, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2021
Discovery of a small protein factor involved in the coordinated degradation of phycobilisomes in cyanobacteriaVanessa Krauspe, Matthias Fahrner, Philipp Spät, et al.
Clinical Proteomics|March 13, 2018
Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinizationMelanie Christine Föll, Matthias Fahrner, Victor Oginga Oria, et al.
Pageof 2